Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Investigate common budgeting blockers that prevent savings and identify actionable changes. This intro guides you toward steady, growing savings.
27,247 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Tilray Brands is set to report on July 28. This article breaks down whether should tilray brands stock be on your rad...
Warren Buffett’s transition at Berkshire Hathaway puts Apple in the spotlight as the conglomerate’s largest public ho...
Standard Chartered trims its XRP outlook to $2.80, a 65% drop that marks the sharpest forecast revision among its cry...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...
Snap Inc has faced a severe share-price drop, but a mix of AR hardware progress, AI-enhanced ads, and international g...
Monster Beverage's 2025 earnings outlook centers on international growth, margin improvements, and strategic branding...
Blend unveils Autopilot AI, a new agent aimed at shaving weeks off mortgage origination. The tool automates document ...
Owlet's Q4 2025 results reveal a company balancing growth with a path toward profitability. This article disentangles...
The weight loss field is heating up, with Novo Nordisk leading the GLP-1 wave and Amgen pursuing a smaller, more sele...
A top AI stock has pulled back while earnings surge, drawing attention from analysts who see significant upside ahead...
Reno has overtaken Las Vegas as the top destination for California homebuyers seeking affordability, driven by supply...